GB0216972D0 - Peptides and peptide derivaties for the treatment of &-synuclein-related diseases - Google Patents

Peptides and peptide derivaties for the treatment of &-synuclein-related diseases

Info

Publication number
GB0216972D0
GB0216972D0 GB0216972A GB0216972A GB0216972D0 GB 0216972 D0 GB0216972 D0 GB 0216972D0 GB 0216972 A GB0216972 A GB 0216972A GB 0216972 A GB0216972 A GB 0216972A GB 0216972 D0 GB0216972 D0 GB 0216972D0
Authority
GB
United Kingdom
Prior art keywords
derivaties
synuclein
peptides
peptide
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0216972A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lancaster University
Original Assignee
Lancaster University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster University filed Critical Lancaster University
Priority to GB0216972A priority Critical patent/GB0216972D0/en
Publication of GB0216972D0 publication Critical patent/GB0216972D0/en
Priority to PCT/GB2003/003240 priority patent/WO2004009625A2/en
Priority to AU2003267532A priority patent/AU2003267532A1/en
Ceased legal-status Critical Current

Links

GB0216972A 2002-07-22 2002-07-22 Peptides and peptide derivaties for the treatment of &-synuclein-related diseases Ceased GB0216972D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0216972A GB0216972D0 (en) 2002-07-22 2002-07-22 Peptides and peptide derivaties for the treatment of &-synuclein-related diseases
PCT/GB2003/003240 WO2004009625A2 (en) 2002-07-22 2003-07-22 PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES
AU2003267532A AU2003267532A1 (en) 2002-07-22 2003-07-22 PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0216972A GB0216972D0 (en) 2002-07-22 2002-07-22 Peptides and peptide derivaties for the treatment of &-synuclein-related diseases

Publications (1)

Publication Number Publication Date
GB0216972D0 true GB0216972D0 (en) 2002-08-28

Family

ID=9940894

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0216972A Ceased GB0216972D0 (en) 2002-07-22 2002-07-22 Peptides and peptide derivaties for the treatment of &-synuclein-related diseases

Country Status (3)

Country Link
AU (1) AU2003267532A1 (en)
GB (1) GB0216972D0 (en)
WO (1) WO2004009625A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080014194A1 (en) 2003-10-31 2008-01-17 Elan Pharmaceuticals, Inc. Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US8697082B2 (en) 2002-11-01 2014-04-15 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US9034337B2 (en) 2003-10-31 2015-05-19 Prothena Biosciences Limited Treatment and delay of outset of synucleinopathic and amyloidogenic disease
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
WO2005047860A2 (en) 2003-11-08 2005-05-26 Elan Pharmaceuticals, Inc. Antibodies to alpha-synuclein
BRPI0620125B1 (en) * 2005-12-22 2022-05-17 Vrije Universiteit Brussel Method for regulating the reduction of biological function of a protein, and method for isolating a protein from a sample
US8147833B2 (en) 2007-02-23 2012-04-03 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
CA2678963C (en) 2007-02-23 2018-05-01 Elan Pharmaceuticals, Inc. Prevention and treatment of synucleinopathic and amyloidogenic disease
GB0716885D0 (en) * 2007-08-30 2007-10-10 United Arab Emirates Universit Diagnostic agent
AT506535B1 (en) 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh VACCINE CONTAINING ALPHA SYNUCLEIN MIMOTOPES BASED ON PEPTIDES
NZ589302A (en) 2008-04-17 2012-11-30 Declion Pharmaceuticals Inc Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
WO2018005867A2 (en) * 2016-06-29 2018-01-04 The Regents Of The University Of California Structure-based peptide inhibitors of alpha-synuclein aggregation
CN106854233B (en) * 2017-03-03 2020-07-17 国家纳米科学中心 Quasi-peptide and preparation method and application thereof
EP3946266A4 (en) * 2019-03-28 2023-07-12 The Chinese University Of Hong Kong Sumo peptides for treating neurodegenerative diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415179A1 (en) * 2000-07-07 2002-01-17 Panacea Pharmaceuticals, Inc. Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases

Also Published As

Publication number Publication date
AU2003267532A1 (en) 2004-02-09
WO2004009625A3 (en) 2004-09-23
WO2004009625A2 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
AU2003239531A8 (en) Protein cages for the delivery of medical imaging and therapy
HK1135330A1 (en) Short bioactive peptides and methods for their use
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003267829A8 (en) Peptides and methods for the control of obesity
GB0216972D0 (en) Peptides and peptide derivaties for the treatment of &-synuclein-related diseases
AU2003267124A8 (en) Bh3 peptides and method of use thereof
EP1514106A4 (en) Targeted therapeutic proteins
IL165998A (en) Growth hormone releasing peptides and their use in the manufacture of medicaments
PL372695A1 (en) Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
IL148401A0 (en) Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
GB0218205D0 (en) Human ZZAP1 protein
AU2003298911A8 (en) Cyclosporins for the treatment of autoimmune diseases
HUP0401536A3 (en) Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
EP1362235A4 (en) Peptide or protein microassay method and apparatus
SI1462455T1 (en) Ser-Ser-Ser-Arg peptide and medicinal uses thereof
AU2003295343A8 (en) Uses of human zven proteins and polynucleotides
IL166706A0 (en) Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
AU2003301843A8 (en) 157 human secreted proteins
AU2003226899A8 (en) Human diabetes-mediating proteins
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
AU2003230144A8 (en) Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases
HK1045103A1 (en) Therapeutic uses of bpi protein products in bpi-deficient humans
AU2003252075A8 (en) Human immunosuppressive protein
GB0201025D0 (en) The treatment of degenerative diseases
AU2002364757A8 (en) Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)